Lv31
214 积分 2023-04-30 加入
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
3天前
已完结
Macular atrophy in neovascular age-related macular degeneration: Prevalence, risk factors, imaging features, and clinical implications
13天前
已完结
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
22天前
已完结
Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society
29天前
已完结
Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society
29天前
已完结
Beyond Longer Intervals: Advocating for Regular Treatment of Neovascular AMD
29天前
已完结
The Impact of Early Residual Fluid After Anti-Vascular Endothelial Growth Factor Initiation in Patients With Neovascular Age-Related Macular Degeneration: A Meta-Analysis Review
29天前
已完结
Optimizing Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration: the Potential Value of Sustained Anti-VEGF Therapy
29天前
已完结
Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
30天前
已完结
Switching to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular edema: a systematic review and meta-analysis
30天前
已完结
皖公网安备34019202002308
